Maya N Clark Cutaia received her PhD from the University of Pittsburgh, School of Nursing, and completed her Post-doctoral work at the University of Pennsylvania, School of Nursing. She is faculty in the Adult Gerontological Acute Care Nurse Practitioner Program, while conducting research that will lead to development and testing of bio-behavioral interventions for symptom management based on explicating biological mechanisms. Her current focus is symptom management in ESRD, with an interest in the impact of recommended dietary sodium intake restrictions on symptoms experienced by hemodialysis patients.
Aim: In hemodialysis, patients need to have intercurrent sodium and water intake removed by ultrafiltration, increases disease burden through the symptoms and signs that occur during hemodialysis (HD). This added burden may be mitigated by reduction of dietary sodium. The National Kidney Foundation (NKF) recommends 2400 mg of dietary sodium daily for patients on HD, and the American Heart Association (AHA) suggests 1500 mg, evidence is lacking, however, to support these recommendations in HD. Moreover, little is known about the relationship of specific levels of dietary sodium intake and the severity of symptoms and signs during ultrafiltration. Our goal will be to determine the effects of carefully-monitored levels of sodium-intake as set forth by the NKF and AHA on symptoms and signs in patients undergoing (HD). Methods: We designed a 3-group (2400 mg, 1500 mg, unrestricted), double blinded randomized controlled trial with a sample of 42 HD participants to determine: Whether symptom profiles and interdialytic weight gain vary among 3 sodium intake groups; the effect of HD-specific on the symptom profiles vary among the 3 groups; and whether total body water extracellular volume and intracellular volume measured with bioimpedance varies across the 3 groups. We will also examine the feasibility of recruitment, enrollment and retention of participants for the 5-day inpatient stay. Conclusion: Curbing sodium intake may lead to improvement in intradialytic symptom amelioration and potential for better long-term outcomes. Generating empirical support will be critical to ascertain and espouse the appropriate level of sodium intake for patients receiving HD.
Khalid Al Matham finished Nephrology Fellowship at Toronto University Canada in 2014. Currently, he is working as Consultant Nephrologist at King Fahad Medical City, and also is the Internal Medicine Residency Training Program Director.
Introduction: Glomerulonephritis (GN) is the inflammation of the capillaries of the glomeruli, characterized by albuminuria, edema and hypertension. The complications of GN can vary from acute renal failure to end stage renal disease. Objective: To evaluate the prevalence and pattern of GN at a single tertiary care center to be an informative and valid evidence to establish a national registry. Methods: A retrospective chart review was conducted of kidney biopsies taken between the period 2007 to 2015. Results: 166 patients were identified for biopsies as GN. The mean age of patients was 28.4±13.23. The most frequent primary GN type was Focal and Segmental Glomerulosclerosis (FSGS) 37 (20.2%). And the most frequent secondary GN was lupus nephritis (LN4) 30 (16.4%). Lupus nephritis 4 (25 cases: 83.3%) and lupus nephritis 3 (18 cases: 82%) were more prevalent among females than males, with a statistically significant difference between genders (p=0.001) and (p=0.012), respectively. Interestingly, Heavy proteinuria was found among MPGN and PIGN patients. Conclusion: Our results support the literature in the high prevalence of FSGS in Saudi Arabia. LN was more prevalent in females, which should be investigated thoroughly in future.